NewsBenzinga로켓 원의 자회사 호스 테라퓨틱스, 중간 효능 데이터 이후 HT-001의 2a상 임상시험 종료 계획 발표···HT-001의 잠재적 3상 임상 프로그램 진행을 위한 FDA 피드백 요청 예정 로켓 원의 자회사 호스 테라퓨틱스, 중간 효능 데이터 이후 HT-001의 2a상 임상시험 종료 계획 발표···HT-001의 잠재적 3상 임상 프로그램 진행을 위한 FDA 피드백 요청 예정 Benzinga 2026.11.03 13:20 (GMT+0) Open on Benzinga Other news Why Aytu Biopharma Shares Are Trading Higher By 43%; Here Are 20 Stocks Moving Premarket Reported Earlier, 'Leak of 15mn Deutsche Bank files exposes systemic failures; Email, internal probes and other documents throw new light on the career and leadership of chief executive Christian Sewing' - FT Exclusive Fed Chair Kevin Warsh Sees Two AI Futures: Productivity Boom or Painful Market Reversal and Job Losses Reported November 16, Roche Receives FDA Approval For Wiserdley In Combination With Everolimus For Breast Cancer Treatment Weibo Q3 Adj. EPS $0.06 Misses $0.24 Estimate, Sales $410.230M Miss $417.238M Estimate Jensen Huang Ran Nvidia Like a 'Family Business' — Where Daughter Madison and Son-In-Law Held Growing Power Amid Workplace Complaints: Report
Reported Earlier, 'Leak of 15mn Deutsche Bank files exposes systemic failures; Email, internal probes and other documents throw new light on the career and leadership of chief executive Christian Sewing' - FT Exclusive
Fed Chair Kevin Warsh Sees Two AI Futures: Productivity Boom or Painful Market Reversal and Job Losses
Reported November 16, Roche Receives FDA Approval For Wiserdley In Combination With Everolimus For Breast Cancer Treatment
Jensen Huang Ran Nvidia Like a 'Family Business' — Where Daughter Madison and Son-In-Law Held Growing Power Amid Workplace Complaints: Report